Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer

Seminars in Oncology

Volumn 28, Issue 1 SUPPL. 2, 2001, Pages 22-27

  Hainsworth, John D ^a   Vokes, Everett E ^a,b  

^a SARAH CANNON RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; GEMCITABINE; MITOMYCIN; NAVELBINE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINDESINE;

ADVANCED CANCER; ASTHENIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; ELDERLY CARE; ESOPHAGITIS; FATIGUE; FEBRILE NEUTROPENIA; GRANULOCYTOPENIA; HUMAN; HYPERSENSITIVITY REACTION; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; NEUTROPENIA; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0035079380     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.18399     Document Type: Review

References (25)

1. Non-small cell lung cancer
2. Role of multimodality treatment for lung cancer
3. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer
4. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies
5. Concomitant chemoradiotherapy: Rationale and clinical experiences in patients with solid tumors
6. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial
7. A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC) (CALGB Study 9431)
8. Clinical studies in non-small cell lung cancer: The CALGB experience
9. A randomized phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with mitomycin (M), vindesine (V), and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC): Preliminary analysis
10. The recent progress in chemoradiotherapy of lung cancer
11. Phase I study of docetaxel with concomitant thoracic radiation therapy
12. Docetaxel-based combined modality therapy for locally advanced carcinoma of the esophagus and gastric cardia
13. Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer: A phase I/II dose escalation trial
14. Concurrent conventionally fractionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
15. Docetaxel (Taxotere) combined with radiation in locally advanced non-small cell lung cancer - A phase I/II study
16. Phase I trial of outpatients weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small cell lung cancer. A Vanderbilt Cancer Center Affiliation Network (VCCAN) trial
17. Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer
18. Phase II trial of docetaxel in patients with stage III and IV non-small cell lung cancer
19. Phase II trials of Taxotere with non-small cell lung cancer
20. Docetaxel (Taxotere) is active in non-small cell lung cancer: A phase II trial of the EORTC Early Clinical Trials group (ECTG)
21. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
22. Phase I study of weekly docetaxel (Taxotere) in heavily pretreated breast cancer patients
23. Activity of weekly Taxotere (TXT) in patients with metastatic breast cancer
24. Weekly Docetaxel in the treatment of elderly patients with advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network phase II trial
25. Docetaxel (Taxotere) administered in weekly schedules